Citation and Traceability for Infectious Disease R&D Document Analysis

Infectious disease R&D documents draw from diverse sources, including clinical trial reports, pathogen genome sequencing data, drug mechanism of

Data Characteristics in this Domain

Infectious disease R&D documents draw from diverse sources, including clinical trial reports, pathogen genome sequencing data, drug mechanism of action studies, epidemiological survey reports, and various scientific literature. Update frequency varies by data type; for example, epidemiological data might update weekly, while clinical trial reports typically release after trial completion. Document structures range from clinical study reports strictly adhering to ICH GCP (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice) to laboratory records containing extensive unstructured text. Fields and units are highly specialized, such as pathogen strains, minimum inhibitory concentration (MIC, unit μg/mL), drug half-life (T1/2, unit hours), and viral load (unit copies/mL). These specialized terms and units demand high accuracy in analysis.

Constraints on Citation and Traceability from these Characteristics

The characteristics of infectious disease R&D documents impose multiple constraints on citation and traceability mechanisms. First, the wide range of data sources requires the knowledge base to integrate documents of different formats and origins. When citing, it must clearly indicate the original source, such as a clinical trial registry or an academic journal. Second, the specialized terminology and units mean that simple keyword matching can lead to ambiguity or incorrect citations. This necessitates more refined semantic understanding to ensure contextual accuracy of citations. For example, a citation for "MIC" must distinguish between in vitro drug activity data and clinical susceptibility results. The varying document update frequencies, especially for epidemiological data, require the citation system to handle and label data timeliness to avoid citing outdated information. Finally, the coexistence of structured and unstructured documents makes it challenging to locate precise citation snippets within unstructured text and link them to their structured background information. This demands robust text parsing and entity recognition capabilities to support traceability.

Configuration Guidelines

Configuration ItemRecommended ValueRationale for Recommendation
Chunk size (Chunk Size)500–800 charactersInfectious disease documents are dense with specialized terms. Shorter chunks help maintain semantic integrity and prevent key information from being truncated.
Recall count (Retrieval Count)Top 10–15Ensures that complex queries cover multiple related but potentially dispersed specialized knowledge points, increasing traceability accuracy.
Similarity threshold (Similarity Threshold)0.78–0.85Balances recall and precision. Avoids misinterpreting semantically similar but professionally unrelated infectious disease data as citations.
Rerank result count (Reranked Return Count)Top 5Infectious disease R&D demands high authority. Reranking elevates the most relevant and authoritative citations to the forefront.
PARSE_FILE_TIMEOUT_SECONDS600 secondsSufficient file parsing time is needed when processing large clinical trial reports or genomic data files.
CHUNK_OVERLAP_SIZE100 charactersEnsures contextual continuity, especially when describing continuous content like drug mechanisms of action or pathogen variations.

Three Common Mistakes

  • The query results include numerous irrelevant document citations. This occurs when the Similarity threshold (Similarity Threshold) is set too low, causing the system to include general medical literature weakly related to infectious diseases.
  • Numerical values or units cited in the answer do not match the original document. This usually happens when Chunk size (Chunk Size) is set improperly, leading to critical values and their units being split during chunking, preventing the model from correct understanding.
  • The API call returns null or an empty string for the cited filename. This indicates that file metadata (e.g., the filename field) was not correctly extracted or stored during knowledge base construction, making it impossible to trace back to the specific file.

How to Verify Configuration

  • Pose questions about drug development for typical infectious diseases (e.g., influenza, HIV). Check if all cited sources are authoritative journals or clinical trial reports in the relevant field, and verify the accuracy of the filename field.
  • Verify that specialized numerical values (e.g., MIC values, viral load) in the answer exactly match the cited document content, including magnitude and units, to confirm that Chunk size (Chunk Size) is appropriately configured.
  • Simulate queries about specific pathogen genome variations. Check if the cited documents can accurately trace back to specific gene sequencing reports or bioinformatics database entries. This assesses whether Recall count (Retrieval Count) and Similarity threshold (Similarity Threshold) can effectively identify subtle differences.

The values provided are common starting points. Measure against your own samples to determine optimal configurations.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.